Park Ha Biological Technology Co., Ltd. - Class A Ordinary Shares (BYAH)

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company’s securities in a registered direct offering (the “Offering”) consisting of up to 1,133,332 of the Company’s Class A ordinary shares, par value $0.001 each (the “Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A ordinary shares (the “Warrant Shares”), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million.

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Star Plus Action (HK) Limited (“Star Plus Action”), a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), a company listed on The Stock Exchange of Hong Kong (“Star Plus Legend”). The two parties will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence technology to jointly advance the beauty and wellness sector, creating an innovative business model that combines AI technology, professional skincare services, and health maintenance. Their first collaborative smart product—the AI Nutritionist—has been launched as a pilot. Moving forward, both parties will accelerate the development and deployment of a full-chain intelligent service system, including AI-powered store managers and AI-driven professional skincare specialists, driving the digital transformation of the skincare and wellness industry.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public.

As digital securities, blockchain-based preferred stock , and tokenized equity frameworks move from concept to real-world execution, early adopters are positioned to benefit most . Full Alliance Group’s (OTC: FAGI ) first-mover position in compliant, blockchain-verified preferred equity , combined with real operating businesses and strategic digital infrastructure exposure , creates a rare asymmetric opportunity within the OTC market.

Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112 per Unit.

Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112  per Unit.